ArticleJCO oncology practice2024

Optimizing Therapy to Match the Risk: Neoadjuvant Approaches to Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Alexandra Thomas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.